Apremilast survival and reasons for discontinuation in psoriasis: five-year experience from a Greek tertiary care centre
Introduction: Drug survival is an indirect measure of efficacy and safety and its post-marketing assessment using real-life data is invaluable. Objectives: To investigate the survival of apremilast in a cohort of psoriasis patients treated with apremilast in a Greek hospital. Methods: A retrospectiv...
Saved in:
Main Authors: | Elena Sotiriou (Author), Aikaterini Tsentemeidou (Author), Nikolaos Sideris (Author), Aimilios Lallas (Author), Nikolaos Kougkas (Author), Dimitrios Ioannides (Author), Efstratios Vakirlis (Author) |
---|---|
Format: | Book |
Published: |
Mattioli1885,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Apremilast in psoriasis patients with serious comorbidities: a case series and systematic review of literature
by: Aikaterini Tsentemeidou, et al.
Published: (2022) -
Adalimumab effect on pain in hidradenitis suppurativa patients: systematic review and meta-analysis
by: Aikaterini Tsentemeidou, et al.
Published: (2022) -
Work Impairment in Hidradenitis Suppurativa Compared to Psoriasis: A Cross-Sectional Study
by: Aikaterini Tsentemeidou, et al.
Published: (2024) -
Scabies escaping detection until dermoscopy was applied
by: Aimilios Lallas, et al.
Published: (2017) -
Photodynamic Therapy for Field Cancerization in the Skin: Where Do We Stand?
by: Aikaterini Bakirtzi, et al.
Published: (2023)